Richard Chin
Director · Cytek Biosciences, Inc.
Individual
- 2025
- Aug 20, 2026
- 6
Other insiders active in the same sector
No other insider has filed at Richard Chin's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- James Edgemond - $201.52M in UTHR purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $199.99M in TYRA purchases and sales in the last 12 months
- Catalyst4, Inc. - $191.21M in MPLT purchases and sales in the last 12 months
- John Oyler - $189.61M in ONC purchases and sales in the last 12 months
- BVF PARTNERS L P - $173.67M in KYMR purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $172.50M in KYMR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Richard Chin?
Richard Chin is a corporate insider, tracked as Director of Cytek Biosciences, Inc. (CTKB). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Richard Chin submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
